Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome

Sleep Medicine

Volumn 10, Issue 1, 2009, Pages 95-103

  Li, Yongxia ^a,b   Chongsuvivatwong, Virasakdi ^b   Geater, Alan ^b   Liu, Ao ^c  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cost effectiveness; Cytokines; Exhaled breath condensate; Inflammation; Obstructive sleep apnea syndrome; Oxidative stress

Indexed keywords

8 ISOPROSTANE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BREATH ANALYSIS; CIGARETTE SMOKING; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; EXHALATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; ROC CURVE; SLEEP APNEA SYNDROME;

ADULT; ANOXIA; BIOLOGICAL MARKERS; BREATH TESTS; CYTOKINES; DINOPROST; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149528681     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2007.11.013     Document Type: Article

References (55)

1. Young T., Palta M., Dempsey J., Skatrud J., Weber S., and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328 (1993) 1230-1235
2. Brooks D., Horner R.L., Kozar L.F., Render-Teixeira C.L., and Phillipson E.A. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99 (1997) 106-109
3. Peppard P.E., Young T., Palta M., and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
4. Bounhoure J.P., Galinier M., Didier A., and Leophonte P. Sleep apnea syndromes and cardiovascular disease. Bull Acad Natl Med 189 (2005) 445-464
5. Dursunoglu D., and Dursunoglu N. Cardiovascular diseases in obstructive sleep apnea. Tuberk Toraks 54 (2006) 382-396
6. Stoohs R., and Guilleminault C. Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol 72 (1992) 583-589
7. Lattimore J.D., Celermajer D.S., and Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 41 (2003) 1429-1437
8. Harbison J., O'Reilly P., and McNicholas W.T. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 118 (2000) 591-595
9. Garpestad E., Katayama H., Parker J.A., et al. Stroke volume and cardiac output decrease at termination of obstructive apneas. J Appl Physiol 73 (1992) 1743-1748
10. Yaggi H.K., Concato J., Kernan W.N., Lichtman J.H., Brass L.M., and Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353 (2005) 2034-2041
11. Arzt M., Young T., Finn L., Skatrud J.B., and Bradley T.D. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 172 (2005) 1447-1451
12. Bloch K.E., Schoch O.D., Zhang J.N., and Russi E.W. German version of the Epworth Sleepiness Scale. Respiration 66 (1999) 440-447
13. Davies R.J., Ali N.J., and Stradling J.R. Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. Thorax 47 (1992) 101-105
14. Williams A.J., Yu G., Santiago S., and Stein M. Screening for sleep apnea using pulse oximetry and a clinical score. Chest 100 (1991) 631-635
15. Carpagnano G.E., Kharitonov S.A., Resta O., Foschino-Barbaro M.P., Gramiccioni E., and Barnes P.J. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest 122 (2002) 1162-1167
16. Yamauchi M., Nakano H., Maekawa J., et al. Oxidative stress in obstructive sleep apnea. Chest 127 (2005) 1674-1679
17. Suratt P.M., Turner B.L., and Wilhoit S.C. Effect of intranasal obstruction on breathing during sleep. Chest 90 (1986) 324-329
18. McNicholas W.T., Tarlo S., Cole P., et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 126 (1982) 625-628
19. Leznoff A., Haight J.S., and Hoffstein V. Reversible obstructive sleep apnea caused by occupational exposure to guar gum dust. Am Rev Respir Dis 133 (1986) 935-936
20. Zwillich C.W., Pickett C., Hanson F.N., and Weil J.V. Disturbed sleep and prolonged apnea during nasal obstruction in normal men. Am Rev Respir Dis 124 (1981) 158-160
21. Wynne J.W. Obstruction of the nose and breathing during sleep. Chest 82 (1982) 657-658
22. Ryan S., Taylor C.T., and McNicholas W.T. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112 (2005) 2660-2667
23. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., Kales A., Tyson K., and Chrousos G.P. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. Clin Endocrinol Metab 82 (1997) 1313-1316
24. Schulz R., Mahmoudi S., Hattar K., et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162 (2000) 566-570
25. Romero P.V., Rodriguez B., Martinez S., Canizares R., Sepulveda D., and Manresa F. Analysis of oxidative stress in exhaled breath condensate from patients with severe pulmonary infections. Arch Bronconeumol 42 (2006) 113-119
26. Shahid S.K., Kharitonov S.A., Wilson N.M., Bush A., and Barnes P.J. Exhaled 8-isoprostane in childhood asthma. Respir Res 6 (2005) 79
27. Montuschi P., Kharitonov S.A., Ciabattoni G., and Barnes P.J. Exhaled leukotrienes and prostaglandins in COPD. Thorax 58 (2003) 585-588
28. Carpagnano G.E., Barnes P.J., Geddes D.M., Hodson M.E., and Kharitonov S.A. Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis. Am J Respir Crit Care Med 167 (2003) 1109-1112
29. Biernacki W.A., Kharitonov S.A., and Barnes P.J. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 58 (2003) 294-298
30. Carpenter C.T., Price P.V., and Christman B.W. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest 114 (1998) 1653-1659
31. Montuschi P., Kharitonov S.A., Ciabattoni G., et al. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 55 (2000) 205-209
32. Janssen L.J. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280 (2001) L1067-L1082
33. Spath-Schwalbe E., Hansen K., Schmidt F., et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab 83 (1998) 1573-1579
34. Shoham S., Davenne D., Cady A.B., Dinarello C.A., and Krueger J.M. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 253 (1987) R142-R149
35. de Vries J.E. Immunosuppressive and anti-inflammatory properties of interleukin-10. Ann Med 27 (1995) 537-541
36. Groux H., and Cottrez F. The complex role of interleukin-10 in autoimmunity. J Autoimmunity 20 (2003) 281-285
37. Rechtshaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. US Government Printing Office. Washington, DC: NIH Publication No. 204, 1986.
38. Diagnosis and Treatment of Obstructive Sleep Apnea. National Guideline Clearinghouse. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2005, 54p. Available from: www.guideline.gov.
39. Study Group of Sleep Respiratory Disease, Branch of Respiratory Diseases, Chinese Medical Association. Guideline for diagnosis and treatment of obstructive sleep hypopnea syndrome. Chin J Tuberc Respir Dis (Chin) 2002; 25: 195-198.
40. Flemons W.W., Buysse D., Redline S., et al. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research - the report of an American Academy of Sleep Medicine task force. Sleep 22 (1999) 667-689
41. Montuschi P., Corradi M., Ciabattoni G., Nightingale J., Kharitonov S.A., and Barnes P.J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 160 (1999) 216-220
42. Carpagnano G.E., Resta O., Foschino-Barbaro M.P., et al. Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys). Eur J Pharmacol 505 (2004) 169-175
43. Alberti A., Sarchielli P., Gallinella E., et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res 12 (2003) 305-311
44. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org, 2007.
45. Chongsuvivatwong V. Epicalc: Epidemiological Calculator. R package version 2.5.1.4. http://www.cran.r-project.org, 2007.
46. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Control 19 6 (1974) 716-723
47. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85 (2000) 1151-1158
48. Liu H., Liu J., Xiong S., Shen G., Zhang Z., and Xu Y. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ 3 (2000) 200-202
49. Minoguchi K., Tazaki T., Yokoe T., et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126 (2004) 1473-1479
50. Yokoe T., Minoguchi K., Matsuo H., et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107 (2003) 1129-1134
51. Carpagnano G.E., Kharitonov S.A., Resta O., Foschino-Barbaro M.P., Gramiccioni E., and Barnes P.J. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124 (2003) 1386-1392
52. Garey K.W., Neuhauser M.M., Robbins R.A., Danziger L.H., and Rubinstein I. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest 125 (2004) 22-26
53. Roth M.D., Arora A., Barsky S.H., Kleerup E.C., Simmons M., and Tashkin D.P. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med 157 (1998) 928-937
54. Baraldi E., Carraro S., Alinovi R., et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 58 (2003) 505-509
55. Bucchioni E., Kharitonov S.A., Allegra L., and Barnes P.J. High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. Respir Med 97 (2003) 1299-1302